Sutro Biopharma (STRO) Operating Margin (QoQ) (2017 - 2025)

Sutro Biopharma (STRO) Operating Margin (QoQ) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Sutro Biopharma 339.58 Mn 175.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -7,656.00
Sep 30, 2025 -49,469.00
Jun 30, 2025 38,853.00
Mar 31, 2025 4,688.00
Dec 31, 2024 35,651.00
Sep 30, 2024 -60,778.00
Jun 30, 2024 24,566.00
Mar 31, 2024 -47,299.00
Dec 31, 2023 29,801.00
Sep 30, 2023 18,345.00
Jun 30, 2023 -11,026.00
Mar 31, 2023 23,697.00
Dec 31, 2022 -48,588.00
Sep 30, 2022 -1,537.00
Jun 30, 2022 59,462.00
Mar 31, 2022 -33,474.00
Dec 31, 2021 7,826.00
Sep 30, 2021 -37,216.00
Jun 30, 2021 9,471.00
Mar 31, 2021 17,044.00